• Non ci sono risultati.

UCCELLA, SILVIA (Primo)CERUTTI RVIGETTI, DAVIDEFURLAN, DANIELAOLDRINI RCARNEVALI IPELOSI GLA ROSA SPASSI, ALBERTO GIUSEPPECAPELLA, CARLO RENATOmostra contributor esterni nascondi contributor esterni 

N/A
N/A
Protected

Academic year: 2021

Condividi "UCCELLA, SILVIA (Primo)CERUTTI RVIGETTI, DAVIDEFURLAN, DANIELAOLDRINI RCARNEVALI IPELOSI GLA ROSA SPASSI, ALBERTO GIUSEPPECAPELLA, CARLO RENATOmostra contributor esterni nascondi contributor esterni "

Copied!
1
0
0

Testo completo

(1)

J Histochem Cytochem. 2006 Aug;54(8):863-75. Epub 2006 Mar 3. [DOI: 10.1369/jhc.5A6770.2006]

Histidine decarboxylase, DOPA decarboxylase, and vesicular monoamine transporter 2 expression in neuroendocrine tumors:

immunohistochemical study and gene expression analysis.

Uccella S, Cerutti R, Vigetti D, Furlan D, Oldrini R, Carnevali I, Pelosi G, La Rosa S, Passi A, Capella C.

Source

Section of Anatomic Pathology, Dept. of Human Morphology, University of Insubria and Ospedale di Circolo, Via Ottorino Rossi, 9 I-21100 Varese, Italy. [email protected]

Abstract

Histidine decarboxylase (HDC) and vesicular monoamine transporter 2 (v-MAT2) are involved in the biosynthesis and storage of histamine. DOPA decarboxylase (DDC) is involved in the biosynthesis of a variety of amines and shares a high degree of homology with HDC. HDC and v-MAT2 immunoreactivities (IR) have recently been detected in well-differentiated neuroendocrine tumors (WDNETs) and poorly differentiated neuroendocrine carcinomas (PDNECs) of various sites and have been proposed as general endocrine markers. We evaluated HDC and v-MAT2 IR in a series of 117 WDNETs and PDNECs from different sites. Western blotting analysis was performed to verify the specificity of anti-DDC and anti-HDC antibodies. Real-time RT-PCR was performed using specific probes for HDC and DDC on 42 cases, examined also for DDC IR. HDC and v-MAT2 IR were observed in the majority of WDNETs and PDNECs of all sites and HDC-IR cases were always also DDC-IR. In contrast, high levels of HDC mRNA were detected only in the gastroenteropancreatic WDNETs, which did not show increased DDC mRNA levels. On the other hand, bronchial carcinoids and lung PDNECs showed high DDC mRNA levels, but nearly undetectable HDC mRNA levels. Western blotting analysis showed a cross-reaction between anti-HDC and anti-DDC antibodies. HDC should not be considered as a general endocrine marker and HDC IR in bronchial carcinoids and PDNECs of the lung can probably be attributed to a cross-reaction with DDC.

Correspondence to: Silvia Uccella, MD, Section of Anatomic Pathology, Dept. of Human Morphology University of Insubria and Ospedale di Circolo, Via Ottorino Rossi, 9 I-21100 Varese, Italy.

E-mail: [email protected]

Received for publication June 23, 2005; accepted February 22, 2006

The Journal of Histochemistry & Cytochemistry

J Histochem Cytochem. 2006 Aug;54(8):863-75. Epub 2006 Mar 3.

PMID: 16517981 [PubMed - indexed for MEDLINE]

©The Histochemical Society, Inc.

Riferimenti

Documenti correlati

This study suggests that the combination of wound bed preparation with application of the hyaluronic regenerative matrix can be a valid approach for treatment of partial

The structure of the resulting nonlinear sigma model allows us to recover the known spin wave results in the collinear regime, supports the presence of an Ising phase transition

In addition, in normal tissues the antibody directed against the recom- binant peptide recognized HGF in G cells of the duodenal mucosa, and in A and B cells of pancreatic islets,

[24] analyzing a series of 79 pituitary ade- nomas, with immunohistochemical (using polyclonal antibodies directed against porcine subunits of I/A) and in situ hybridization

Gastroenteropancreatic (GEP) endo- crine cells and endocrine tumors (ETs) produce several growth factors, but it is not well known whether they express follistatin and the

Christofori G, Naik P, Hanahan D: Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet

Experimental Design: Twenty-four well-differentiated ETs or carcinomas (WDET/Cs; 11 pancreatic, 3 gastric, and 10 intestinal) and 14 poorly differentiated

The loss of heterozygosity (LOH) analysis showed concurrent losses of the same allele in both the endocrine and exocrine components in all of the five mixed tumors composed by a